Alterations in homologous recombination pathway genes have been extensively studied in cancer, due to their high suitability for cancer hereditary syndromes in pathologic BRCA1/2 germline mutation carriers. The gene discussed is BRCA1; the disease is Inherited cancer-predisposing syndrome.